Literature DB >> 2207427

Outcome of renal replacement treatment in patients with diabetes mellitus.

M A McMillan1, J D Briggs, B J Junor.   

Abstract

OBJECTIVE: To compare the outcome of renal replacement treatment in patients with diabetes mellitus and in non-diabetic patients with end stage renal failure.
DESIGN: Retrospective comparison of cases and matched controls.
SETTING: Renal unit, Western Infirmary, Glasgow, providing both dialysis and renal transplantation. PATIENTS: 82 Diabetic patients starting renal replacement treatment between 1979 and 1988, compared with 82 matched non-diabetic controls with renal failure and 39 different matched controls undergoing renal transplantation. MAIN OUTCOME MEASURES: Patient characteristics, history of smoking, prevalence of left ventricular hypertrophy and myocardial ischaemia at start of renal replacement treatment; survival of patients with renal replacement treatment and of patients and allografts with renal transplantation.
RESULTS: The overall survival of the diabetic patients during the treatment was 83%, 59%, and 50% at one, three, and five years. Survival was significantly poorer in the diabetic patients than the controls (p less than 0.001). Particularly adverse features for outcome at the start of treatment were increasing age (p less than 0.01) and current cigarette smoking (relative risk (95% confidence interval) 2.28 (0.93 to 4.84), p less than 0.05). Deaths were mainly from cardiac and vascular causes. The incidence of peritonitis in patients on continuous ambulatory peritoneal dialysis was the same in diabetic patients and controls (49% in each group remained free of peritonitis after one year), and the survival of renal allografts was not significantly worse in diabetic patients (p less than 0.5).
CONCLUSIONS: Renal replacement treatment may give good results in diabetic patients, although the outlook remains less favourable than for non-diabetic patients because of coexistent, progressive vascular disease, which is more severe in older patients.

Entities:  

Mesh:

Year:  1990        PMID: 2207427      PMCID: PMC1663846          DOI: 10.1136/bmj.301.6751.540

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  18 in total

1.  Tyramine in wine and beer.

Authors:  P Hannah; V Glover; M Sandler
Journal:  Lancet       Date:  1988-04-16       Impact factor: 79.321

2.  Proteinuria: value as predictor of cardiovascular mortality in insulin dependent diabetes mellitus.

Authors:  K Borch-Johnsen; S Kreiner
Journal:  Br Med J (Clin Res Ed)       Date:  1987-06-27

3.  Blood lipid concentrations and other cardiovascular risk factors: distribution, prevalence, and detection in Britain.

Authors:  J I Mann; B Lewis; J Shepherd; A F Winder; S Fenster; L Rose; B Morgan
Journal:  Br Med J (Clin Res Ed)       Date:  1988-06-18

4.  Causes of death in diabetic patients with impaired renal function. An audit of a hospital diabetic clinic population.

Authors:  A D Paterson; T L Dornan; I Peacock; R P Burden; A G Morgan; R B Tattersall
Journal:  Lancet       Date:  1987-02-07       Impact factor: 79.321

Review 5.  Current concepts. Continuous ambulatory peritoneal dialysis.

Authors:  K D Nolph; A S Lindblad; J W Novak
Journal:  N Engl J Med       Date:  1988-06-16       Impact factor: 91.245

6.  Survival on renal replacement therapy: data from the EDTA Registry.

Authors:  F P Brunner; W Fassbinder; M Broyer; R Oulès; H Brynger; G Rizzoni; S Challah; N H Selwood; S R Dykes; A J Wing
Journal:  Nephrol Dial Transplant       Date:  1988       Impact factor: 5.992

7.  Outcome in patients on continuous ambulatory peritoneal dialysis and haemodialysis: 4-year analysis of a prospective multicentre study.

Authors:  R Gokal; C Jakubowski; J King; L Hunt; S Bogle; R Baillod; F Marsh; C Ogg; D Oliver; M Ward
Journal:  Lancet       Date:  1987-11-14       Impact factor: 79.321

8.  Red wine as a cause of migraine.

Authors:  J T Littlewood; C Gibb; V Glover; M Sandler; P T Davies; F C Rose
Journal:  Lancet       Date:  1988-03-12       Impact factor: 79.321

9.  Cigarette-smoking as a risk factor for macroproteinuria and proliferative retinopathy in type 1 (insulin-dependent) diabetes.

Authors:  I Mühlhauser; P Sawicki; M Berger
Journal:  Diabetologia       Date:  1986-08       Impact factor: 10.122

10.  Prevalence of microalbuminuria, arterial hypertension, retinopathy and neuropathy in patients with insulin dependent diabetes.

Authors:  H H Parving; E Hommel; E Mathiesen; P Skøtt; B Edsberg; M Bahnsen; M Lauritzen; P Hougaard; E Lauritzen
Journal:  Br Med J (Clin Res Ed)       Date:  1988-01-16
View more
  6 in total

1.  Influence of vascular access type on sex and ethnicity-related mortality in hemodialysis-dependent patients.

Authors:  Karen Woo; Janis Yao; David Selevan; Robert J Hye
Journal:  Perm J       Date:  2012

2.  Long-term clinical outcomes of peritoneal dialysis patients: 9-year experience of a single center from north India.

Authors:  Sanjay Vikrant
Journal:  Perit Dial Int       Date:  2014-01-02       Impact factor: 1.756

3.  Cardiac disease in diabetic end-stage renal disease.

Authors:  R N Foley; B F Culleton; P S Parfrey; J D Harnett; G M Kent; D C Murray; P E Barre
Journal:  Diabetologia       Date:  1997-11       Impact factor: 10.122

4.  Survival in dialysis patients is not different between patients with diabetes as primary renal disease and patients with diabetes as a co-morbid condition.

Authors:  Marielle A Schroijen; Olaf M Dekkers; Diana C Grootendorst; Marlies Noordzij; Johannes A Romijn; Raymond T Krediet; Elisabeth W Boeschoten; Friedo W Dekker
Journal:  BMC Nephrol       Date:  2011-12-19       Impact factor: 2.388

Review 5.  Diabetes and end-stage renal disease; a review article on new concepts.

Authors:  Seyed Bahman Ghaderian; Fatemeh Hayati; Shokouh Shayanpour; Seyed Seifollah Beladi Mousavi
Journal:  J Renal Inj Prev       Date:  2015-06-01

6.  Cigarette smoking: an important renal risk factor - far beyond carcinogenesis.

Authors:  S R Orth
Journal:  Tob Induc Dis       Date:  2002-06-15       Impact factor: 2.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.